| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,647 |
8,878 |
$672K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,895 |
2,546 |
$235K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,809 |
3,222 |
$213K |
| S9083 |
Global fee urgent care centers |
1,812 |
1,582 |
$211K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,294 |
1,154 |
$91K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,362 |
2,566 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,563 |
2,778 |
$34K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
358 |
299 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,339 |
2,414 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
791 |
573 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,181 |
2,448 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
268 |
226 |
$5K |
| 87807 |
|
63 |
61 |
$220.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
343 |
228 |
$193.53 |
| 81003 |
|
110 |
93 |
$90.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
176 |
120 |
$50.40 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
87 |
79 |
$0.00 |